Clinical Trial Update: Tezepelumab PRO Study

View source ↗

Summary

Update on the tezepelumab PRO study indicating the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezspire (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Status: COMPLETED